| Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects (NCT02175238) | Boehringer Ingelheim | 2014-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 639667 (NCT02133482) | Boehringer Ingelheim | 2014-07-01 |
| Weekly Intravenous Administrations of BI 836845 in Japanese Patients With Advanced Solid Tumours (NCT02145741) | Boehringer Ingelheim | 2014-06-11 |
| A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration (NCT02121522) | Boehringer Ingelheim | 2014-06-01 |
| Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy (NCT02173769) | Boehringer Ingelheim | 2014-06-01 |
| Relative Bioavailability of a BI 187004 Tablet Formulation in Comparison With an Oral Solution and the Influence of Food on the Tablet Formulation in Healthy Volunteers (NCT02161432) | Boehringer Ingelheim | 2014-06-01 |
| Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus (NCT02121483) | Boehringer Ingelheim | 2014-06-01 |
| Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa (NCT02149303) | Boehringer Ingelheim | 2014-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee (NCT02126826) | Boehringer Ingelheim | 2014-05-28 |
| BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer (NCT02123823) | Boehringer Ingelheim | 2014-05-15 |
| Long-term Observation PMS for Afatinib (NCT02131259) | Boehringer Ingelheim | 2014-05-07 |
| Reversal of Dabigatran Anticoagulant Effect With Idarucizumab (NCT02104947) | Boehringer Ingelheim | 2014-05-06 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects (NCT02121509) | Boehringer Ingelheim | 2014-05-01 |
| Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male Subjects (NCT02109679) | Boehringer Ingelheim | 2014-05-01 |
| Afatinib in Subjects With Kidney Dysfunction (NCT02096718) | Boehringer Ingelheim | 2014-05-01 |
| Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use (NCT02129192) | Boehringer Ingelheim | 2014-05-01 |
| Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns (NCT02138097) | Boehringer Ingelheim | 2014-05-01 |
| Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy (NCT02140645) | Boehringer Ingelheim | 2014-05-01 |
| Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients (NCT02126865) | Boehringer Ingelheim | 2014-05-01 |
| Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers (NCT02102932) | Boehringer Ingelheim | 2014-05-01 |
| Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects (NCT02148107) | Boehringer Ingelheim | 2014-05-01 |
| Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use (NCT02121535) | Boehringer Ingelheim | 2014-04-01 |
| To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers (NCT02093819) | Boehringer Ingelheim | 2014-04-01 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects. (NCT02084056) | Boehringer Ingelheim | 2014-04-01 |
| A Study to Investigate the Phototoxic Potential of Faldaprevir (NCT02114671) | Boehringer Ingelheim | 2014-04-01 |
| Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets (NCT02106923) | Boehringer Ingelheim | 2014-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers (NCT02106247) | Boehringer Ingelheim | 2014-04-01 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects (NCT02084082) | Boehringer Ingelheim | 2014-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809 (NCT02068690) | Boehringer Ingelheim | 2014-03-20 |
| Sequential Expansion of Comparative Effectiveness of Anticoagulants (NCT02081807) | Boehringer Ingelheim | 2014-03-07 |
| GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations (NCT02047903) | Boehringer Ingelheim | 2014-03-05 |
| Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy Volunteers (NCT02036775) | Boehringer Ingelheim | 2014-03-01 |
| To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways (NCT02085161) | Boehringer Ingelheim | 2014-03-01 |
| Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events (NCT02096731) | Boehringer Ingelheim | 2014-03-01 |
| Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations (NCT02044380) | Boehringer Ingelheim | 2014-03-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers (NCT02057835) | Boehringer Ingelheim | 2014-03-01 |
| Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers (NCT02096744) | Boehringer Ingelheim | 2014-03-01 |
| Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain (NCT02084511) | Boehringer Ingelheim | 2014-03-01 |
| BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab (NCT02054481) | Boehringer Ingelheim | 2014-02-01 |
| Pharmacokinetics and Safety in Healthy Volunteers (NCT02045979) | Boehringer Ingelheim | 2014-01-31 |
| Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) (NCT02003573) | Boehringer Ingelheim | 2014-01-29 |
| Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers (NCT02037165) | Boehringer Ingelheim | 2014-01-21 |
| Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers (NCT02030535) | Boehringer Ingelheim | 2014-01-01 |
| Safety, Tolerability, Pharmacokinetics of Single Rising Oral Doses of BI 1181181 in Healthy Male Volunteers, Including Investigation of the Effect of Food on the Bioavailability of BI 1181181 (NCT02044406) | Boehringer Ingelheim | 2014-01-01 |
| Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa (NCT02022020) | Boehringer Ingelheim | 2014-01-01 |
| Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets (NCT02028767) | Boehringer Ingelheim | 2014-01-01 |
| Interaction of BI 691751 With Itraconazole (NCT02044393) | Boehringer Ingelheim | 2014-01-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects (NCT02028780) | Boehringer Ingelheim | 2014-01-01 |
| The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage (NCT02043808) | Boehringer Ingelheim | 2014-01-01 |
| Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers (NCT02044367) | Boehringer Ingelheim | 2014-01-01 |
| Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). (NCT02009761) | Boehringer Ingelheim | 2013-12-18 |
| Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours (NCT02020577) | Boehringer Ingelheim | 2013-12-01 |
| Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus (NCT02016625) | Boehringer Ingelheim | 2013-12-01 |
| Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) (NCT01979952) | Boehringer Ingelheim | 2013-11-26 |
| Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML (NCT01957644) | Boehringer Ingelheim | 2013-11-06 |
| Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2) (NCT02006732) | Boehringer Ingelheim | 2013-11-01 |
| Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days (NCT01969747) | Boehringer Ingelheim | 2013-11-01 |
| Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1) (NCT01964352) | Boehringer Ingelheim | 2013-11-01 |
| Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and Levonorgestrel (NCT01941615) | Boehringer Ingelheim | 2013-11-01 |
| Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects (NCT01983566) | Boehringer Ingelheim | 2013-11-01 |
| Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. (NCT01947153) | Boehringer Ingelheim | 2013-11-01 |
| Add-on to Micamlo BP Trial (NCT01975246) | Boehringer Ingelheim | 2013-11-01 |
| Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known (NCT01971476) | Boehringer Ingelheim | 2013-10-22 |
| Ventilator Adapters for Combivent Respimat (NCT01969539) | Boehringer Ingelheim | 2013-10-14 |
| Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets (NCT01975220) | Boehringer Ingelheim | 2013-10-01 |
| Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects. (NCT01965431) | Boehringer Ingelheim | 2013-10-01 |
| Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients (NCT01969721) | Boehringer Ingelheim | 2013-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469 (NCT01971502) | Boehringer Ingelheim | 2013-10-01 |
| Ipratropium Bromide in Peri-Operative COPD (NCT01943552) | Boehringer Ingelheim | 2013-10-01 |
| Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients (NCT01957657) | Boehringer Ingelheim | 2013-10-01 |
| Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers (NCT01958060) | Boehringer Ingelheim | 2013-10-01 |
| Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary (NCT01971086) | Boehringer Ingelheim | 2013-10-01 |
| Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation (NCT01953913) | Boehringer Ingelheim | 2013-09-30 |
| Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular Lymphoma (NCT01950273) | Boehringer Ingelheim | 2013-09-27 |
| Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) (NCT01895777) | Boehringer Ingelheim | 2013-09-25 |
| Nintedanib (BIBF 1120) in Mesothelioma (NCT01907100) | Boehringer Ingelheim | 2013-09-19 |
| BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors (NCT01938846) | Boehringer Ingelheim | 2013-09-05 |
| GLORIA-AF Registry Program (Phase II/III) (NCT01937377) | Boehringer Ingelheim | 2013-09-02 |
| Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran (NCT01955720) | Boehringer Ingelheim | 2013-09-01 |
| Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus (NCT01947855) | Boehringer Ingelheim | 2013-09-01 |
| Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion (NCT01958164) | Boehringer Ingelheim | 2013-09-01 |
| BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis (NCT01958008) | Boehringer Ingelheim | 2013-09-01 |
| Iota-Carrageenan Nasal Spray in Common Cold (NCT01944631) | Boehringer Ingelheim | 2013-09-01 |
| Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male Volunteers (NCT01917916) | Boehringer Ingelheim | 2013-08-05 |
| Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers (NCT01922349) | Boehringer Ingelheim | 2013-08-01 |
| Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain (NCT01929031) | Boehringer Ingelheim | 2013-08-01 |
| Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain (NCT01929044) | Boehringer Ingelheim | 2013-08-01 |
| An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s) (NCT01853826) | Boehringer Ingelheim | 2013-07-17 |
| A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea (NCT01903356) | Boehringer Ingelheim | 2013-07-11 |
| Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) (NCT01897532) | Boehringer Ingelheim | 2013-07-10 |
| A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer (NCT01905111) | Boehringer Ingelheim | 2013-07-01 |
| Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function (NCT01896297) | Boehringer Ingelheim | 2013-07-01 |
| Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions (NCT01897597) | Boehringer Ingelheim | 2013-07-01 |
| PMS of Trazenta on the Long-term Use as Add-on Therapy (NCT01904383) | Boehringer Ingelheim | 2013-07-01 |
| Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine (NCT01911780) | Boehringer Ingelheim | 2013-07-01 |
| Safety and Tolerability of BI 409306 in Patients With Schizophrenia (NCT01892384) | Boehringer Ingelheim | 2013-06-28 |
| LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy (NCT01856478) | Boehringer Ingelheim | 2013-06-07 |
| Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate (NCT01879371) | Boehringer Ingelheim | 2013-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 187004 in Patients With Type 2 Diabetes Mellitus (NCT01874483) | Boehringer Ingelheim | 2013-06-01 |
| Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy Controls (NCT01867307) | Boehringer Ingelheim | 2013-06-01 |